Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
Clinical trial NCT01673490 · TERMINATED
Trial details
- NCT number
- NCT01673490
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-29
- Primary completion
- 2015-03-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.